OFLOWIN OZ TABLET contains Ornidazole, Ofloxacin, and Lactic Acid Bacillus which belongs to the group of medicines called Nitroimidazoles, Fluoroquinolones and Probiotics. OFLOWIN OZ TABLET is used management of various bacterial infections gastrointestinal infections, chest infections, gynaecological infections, dental infections, skin infections and other bacterial and protozoal infections.
OFLOWIN OZ TABLET is not recommended for use in patients suffering from epilepsy (seizures), pre-existing central nervous disorders, tendinitis (inflammation and swelling of tendons of wrist or heel) after management with quinolone antibiotics such as ciprofloxacin, norfloxacin, nadifloxacin etc, glucose-6-phosphate deficiency dehydrogenase deficiency (an inherited condition which can cause haemolytic anaemia).
OFLOWIN OZ TABLET should be used with caution in patients with a history of an aneurysm (bulge or enlargement of large blood vessel), aortic dissection episode (a tear in the wall of the aorta), heart valve regurgitation (leaking of heart valves), connective tissue disorders ex Sjogren syndrome (autoimmune disorder affecting salivary glands, joints and tear glands), Marfan syndrome, Ehlers Danlos syndrome, turner syndrome, vascular disorders such as Takayasu arteritis, giant cell arteritis, Bechet’s disease, high blood pressure, rheumatoid arthritis (inflammation of joints), endocarditis (an infection of the heart), diabetes, low blood sugar, myasthenia gravis (severe muscle weakness), history of heart attack, heart failure, bradycardia( slow heartbeat), salt imbalance in the blood such as low potassium, magnesium levels, if you have or have a family history of prolonged QT interval (irregular heartbeat), heart disorders, liver disorders, kidney disorders, have or ever had a mental illness.
OFLOWIN OZ TABLET is not recommended for use in pregnant women. OFLOWIN OZ TABLET is not recommended for use in breastfeeding women as it is not known whether it passes through...
No content available
